RxDoctor Payments Data

Venkata Muddana, MD

Gastroenterology · Cincinnati, OHNPI 1912055237

Payments from drug & device makers

$11,634in general payments, 2019–2025

Across 111 payments — averaging $104.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumendi LLC$5K
  • ERBE USA Inc$3K
  • Apollo Endosurgery US Inc$975
  • Olympus America Inc.$730
  • Boston Scientific$557
  • Takeda Pharmaceuticals U.S.A., Inc.$382
  • plus $2K from 14 others

What the payments were for

  • Consulting fees$3,70032%
  • Speaking & faculty fees$2,50021%
  • Travel & lodging$1,83016%
  • Food & beverage$3,60331%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,634 in reported general payments places this provider in the 70th percentile of 657 gastroenterology providers in Ohio.

See all gastroenterology providers in Ohio

Medicare billing

Part B allowed, 2024
$125,339
Medicare patients
310
Services billed
749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide22$20,099
Sucralfate21$1,456
Omeprazole100$931
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates11$755
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg28$454
Pantoprazole Sodium40$436
Dicyclomine Hcl17$271
Fluconazole14$99
Ondansetron Hcl18$62
Oxycodone Hcl11$54

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$363$20,09922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 657 gastroenterology providers in Ohio.

Other gastroenterology in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →